ABT vs GILD

Abbott Laboratories against Gilead Sciences — live side-by-side technical comparison.

Prices as of 2026-11-09T20:59:59+00:00 UTC · updates daily

Who leads right now

GILD leads 5 of the 7 windows we measure — over 1 month ABT is +11.0% and GILD +12.0%; over year to date ABT is -11.8% and GILD +38.0%. The ABT/GILD price ratio stands at 0.6528, below its 50-day average of 0.6782, and below the 200-day average of 0.7202. A ratio above its own average means ABT is gaining on GILD; on this reading the recent edge belongs to GILD.

ABT/GILD over the last year

ABT/GILD price ratio · dashed: its 50- and 200-day lines · ratio above its 50-day line = ABT gaining on GILD
0.59550.80121.0071.213
Both rebased to 100 on 2025-11-07
91.41100120.7146.6ABTGILD
Ask
Compare ABT and GILD: which has been stronger over the last year, and where does each stand against its 200-day average? Ask the analyst about this pair →

Performance side by side

ABTGILD
Price$110.53 $169.32
1 day +0.6% +1.5%lead
5 days +0.3%lead -0.6%
1 month +11.0% +12.0%lead
6 months +31.1%lead +28.9%
Year to date -11.8% +38.0%lead
1 year -12.5% +42.5%lead
2 years -5.2% +75.3%lead
52-week position 57% of range 88% of range
52-week range $81.97–$132.03 $116.88–$176.58
vs 50-day average above $103.97 above $153.51
vs 200-day average above $101.52 above $141.13
RSI (14) 59 63
Market cap$190.4B$207.0B
Analyst target $118.52 (+7.8%) $174.77 (+4.7%)
Analysts2626
ConsensusBuyBuy
Next earnings Jan 28, 2027 Oct 29, 2026

Where each one stands

ABT — Abbott Laboratories

ABT trades at $110.53, above its 50-day average of $103.97, and above the 200-day at $101.52. It sits at 57% of its 52-week range ($81.97–$132.03); 14-day RSI is 59, in neutral territory; an average session moves it about 3.2%. For levels, the first level overhead is $110.61 (0.1% away) and the first support below is $104.55 (5.4% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.

GILD — Gilead Sciences

GILD trades at $169.32, above its 50-day average of $153.51, and above the 200-day at $141.13. It sits at 88% of its 52-week range ($116.88–$176.58); 14-day RSI is 63, in neutral territory; an average session moves it about 3.2%. For levels, the first level overhead is $174.48 (3.0% away) and the first support below is $153.51 (9.3% down). On the checklist the page runs for every asset, 5 of 6 checks read bullish — the lean is bullish.

Which one moves harder

Both move about the same amount day to day (3.2% and 3.2% of price), so the same position size carries comparable risk in either.

What would change the picture

The comparison turns on those levels: ABT clearing $110.61 or losing $104.55; GILD clearing $174.48 or losing $153.51. Until one of them gives way, the relative reading above stands.

Questions people ask about ABT vs GILD

Which is performing better right now, ABT or GILD?
Over the past month ABT is +11.0% and GILD is +12.0%, so GILD is ahead on that window. Year to date the figures are -11.8% for ABT and +38.0% for GILD.
Which has done better over the last year, ABT or GILD?
Over the last year ABT is -12.5% and GILD is +42.5%, so GILD is ahead on that window. Over two years it is -5.2% against +75.3%.
Is ABT or GILD more volatile?
Both move about the same amount day to day (3.2% and 3.2% of price), so the same position size carries comparable risk in either.
What are the key levels for ABT and GILD?
ABT: resistance $110.61, support $104.55; GILD: resistance $174.48, support $153.51. Levels come from recent swing zones and round numbers, recomputed daily.
When do ABT and GILD report next?
ABT: Jan 28, 2027. GILD: Oct 29, 2026. Earnings reset both the trend and the levels above, so a comparison made today is only good until the next report.
What does the ABT/GILD ratio mean?
It is simply ABT's price divided by GILD's — 0.6528 today. When the ratio rises, ABT is outperforming; when it falls, GILD is. Comparing it to its own 50- and 200-day averages shows whether the current leadership is new or long-standing.

Full technical briefs

ABT →
Abbott Laboratories
Full technical brief: trend, levels, chart, news
GILD →
Gilead Sciences
Full technical brief: trend, levels, chart, news

Related comparisons

JNJ vs LLYABBV vs LLYLLY vs MerckLLY vs UNHLLY vs TMOAMGN vs LLYGILD vs LLYABT vs LLY